Literature DB >> 11476262

The nonmedical use of ketamine, part two: A review of problem use and dependence.

K L Jansen1, R Darracot-Cankovic.   

Abstract

This is the second part of a review of the nonmedical use of ketamine. Part one discussed the history of ketamine, the sought-after effects for which it is taken in a nonmedical context, how these are produced, common adverse effects, the ketamine schizophrenia model and the neurotoxicity issue. Part two reviews what is currently known about problem use of ketamine, ketamine dependence, treatment options and harm minimization issues. Some ketamine users become dependent on the drug in a manner resembling cocaine dependence, with craving and a high tolerance but no evidence of a physiological withdrawal syndrome. The likely mechanisms of this dependence are discussed in terms of what is known about the neurochemistry of ketamine, its psychological effects, and published case histories in both the formal and informal literature. The conclusions are that ketamine dependence is linked with effects that this complex drug has in common with not only cocaine and amphetamine but also with opiates, alcohol and cannabis, as well as the psychological attractions of its distinctive psychedelic properties.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11476262     DOI: 10.1080/02791072.2001.10400480

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  21 in total

1.  ["Keta" (ketamine): from medication to drug abuse. Bio-psycho-social clinical profile of users and some therapy proposals].

Authors:  J Royo-Isach; M Magrané; M Domingo; B Cortés
Journal:  Aten Primaria       Date:  2004 Jul-Aug       Impact factor: 1.137

2.  [Drugs for intravenous induction of anesthesia: ketamine, midazolam and synopsis of current hypnotics].

Authors:  E Halbeck; C Dumps; D Bolkenius
Journal:  Anaesthesist       Date:  2018-08       Impact factor: 1.041

Review 3.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms.

Authors:  Panos Zanos; Ruin Moaddel; Patrick J Morris; Lace M Riggs; Jaclyn N Highland; Polymnia Georgiou; Edna F R Pereira; Edson X Albuquerque; Craig J Thomas; Carlos A Zarate; Todd D Gould
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

5.  Reinforcing properties of an intermittent, low dose of ketamine in rats: effects of sex and cycle.

Authors:  Katherine N Wright; Caroline E Strong; Marjorie N Addonizio; Naomi C Brownstein; Mohamed Kabbaj
Journal:  Psychopharmacology (Berl)       Date:  2016-11-11       Impact factor: 4.530

6.  Ketamine sensitization: Influence of dose, environment, social isolation and treatment interval.

Authors:  Keith A Trujillo; Colleen Y Heller
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

7.  Ketamine beyond anesthesia: Antidepressant effects and abuse potential.

Authors:  Keith A Trujillo; Sergio D Iñiguez
Journal:  Behav Brain Res       Date:  2020-07-31       Impact factor: 3.332

8.  The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components.

Authors:  Patrick M Connolly; Christina Maxwell; Yuling Liang; Jonathan B Kahn; Stephen J Kanes; Ted Abel; Raquel E Gur; Bruce I Turetsky; Steven J Siegel
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

Review 9.  Ketamine : from medicine to misuse.

Authors:  Kim Wolff; Adam R Winstock
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

10.  The epidemiology and patterns of acute and chronic toxicity associated with recreational ketamine use.

Authors:  Sarbjeet S Kalsi; David M Wood; Paul I Dargan
Journal:  Emerg Health Threats J       Date:  2011-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.